Rizvi Hasan, Butler Tom, Calaminici Mariarita, Doobaree Indraraj U, Nandigam Raghava C, Bennett Dimitri, Provan Drew, Newland Adrian C
Department of Pathology, Barts Health NHS Trust, London, UK; Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK.
Br J Haematol. 2015 May;169(4):590-4. doi: 10.1111/bjh.13330. Epub 2015 Mar 5.
Fibrosis has been reported in some patients with immune thrombocytopenia (ITP) treated with thrombopoietin receptor agonists (TPO-RA). However, fibrosis has also been reported in patients with various stages of ITP, who were TPO-RA treatment-naïve. In our study, we looked for fibrosis in bone marrow trephine biopsies taken at initial diagnosis from 32 adult patients with ITP. Ten of the 32 evaluated samples (31·25%) showed increased reticulin (Grade 1-2 on Bauermeister scale and Grade 0-1 on the European Consensus scale), which showed a positive correlation with ethnicity (0·3%) but did not correlate with disease severity, any clinical features or co-morbidities.
在一些接受血小板生成素受体激动剂(TPO-RA)治疗的免疫性血小板减少症(ITP)患者中已报告有纤维化情况。然而,在未接受过TPO-RA治疗的处于ITP不同阶段的患者中也有纤维化的报告。在我们的研究中,我们在32例成年ITP患者初诊时所取的骨髓活检组织中寻找纤维化情况。32份评估样本中有10份(31.25%)显示网硬蛋白增加(根据鲍ermeister分级为1 - 2级,根据欧洲共识分级为0 - 1级),其与种族呈正相关(0.3%),但与疾病严重程度、任何临床特征或合并症均无关联。